Sofia Mensurado

Sofia Mensurado (1992) is a Portuguese scientist whose research focuses on molecular processes in breast cancer immunotherapy.

Her doctoral project, entitled "Regulation of T cell fitness and function in the tumour microenvironment", was funded with a doctoral scholarship from the FCT (Foundation for Science and Technology) in 2015.

In April 2016, she received an award from the Portuguese Society of Immunology for a trip abroad.

Her team won the Janssen prize in 2018.

Sofia Mensurado Silva graduated in medical sciences from the University of Lisbon and did her master's degree in biochemistry at the Faculty of Sciences of the University of Lisbon, developing her thesis at the iMM (João Lobo Antunes Institute of Molecular Medicine).

She did her PhD in Bruno Silva-Santos' laboratory at the same institute.

In 2018, together with Bruno Silva-Santos and Karine Serre, he won the 2nd edition of the Janssen Innovation prize, worth €30,000, for the research "Tumor-associated neutrophils suppress pro-tumoral IL-17+ γδ T cells through induction of oxidative stress".

This study was also supported by the iMM-Laço Fund, awarded by Associação Laço in partnership with iMM (Instituto de Medicina Molecular – João Lobo Antunes).

She has co-authored several scientific articles:

Since 2020, she has been a postdoctoral researcher at the iMM.

Her research studies the role of T lymphocytes in the immune response to cancer, specifically the neutralization of gamma-delta T cells, which help tumor proliferation.

Sofia Mensurado studies the efficacy of methionine (an amino acid, a component of proteins, present in our diet) in boosting immunotherapy as a treatment for breast cancer.